Suprised at the apathyI am surprised at the people who a few days after the company just increased their (run rate)
- Revenue and EBITDA by about 40% per share,
- Net income by about 100% per share,
by taking on a modest amount of debt at low interest,
decide to hand over their shares for something like 4x EBITDA.
This is a profitable healthtech company operating in Canada, in a non-cyclical business area, with substantial growth ahead. What are these people doing with their money that I am failing to see?